Stocktoria
CorMedix Inc. CRMD
CorMedix Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $311.7M | $43.5M | — | $65,408 | $190,936 | $239,231 | $283,266 | $429,797 | $329,327 | $224,105 |
| Gross profit | $275.7M | $40.3M | — | $61,674 | $41,998 | $34,385 | -$89,968 | $33,011 | $214,363 | -$142,568 |
| R&D expense | $19.3M | $3.9M | $13.2M | $10.7M | $13.1M | $13.4M | $11.1M | $18.8M | $24.5M | $15.7M |
| SG&A expense | — | — | $35.8M | $20.0M | $16.3M | $13.9M | $9.9M | $8.1M | — | — |
| Operating income | $150.1M | -$22.4M | -$49.0M | -$30.6M | -$29.4M | -$27.2M | -$21.0M | -$26.9M | -$32.9M | -$24.8M |
| Interest expense | — | — | $34,296 | $26,515 | $15,943 | $33,226 | $787,488 | $1,873 | $5,619 | $1,311 |
| Income tax | -$13.0M | -$1.4M | — | -$585,617 | -$1.3M | -$5.2M | -$5.1M | — | — | — |
| Net income | $163.1M | -$17.9M | -$46.3M | -$29.7M | -$28.2M | -$22.0M | -$16.4M | -$26.8M | -$33.0M | -$24.6M |
| EPS (diluted) | $2.04 | $-0.30 | $-0.91 | $-0.74 | $-0.75 | — | — | — | — | — |
| Operating cash flow | $175.0M | -$50.6M | -$38.4M | -$24.4M | -$21.2M | -$22.0M | -$15.1M | -$23.7M | -$28.6M | -$22.3M |
| Free cash flow | $172.8M | -$50.7M | -$38.7M | -$24.6M | -$22.6M | -$22.1M | -$15.1M | -$23.7M | -$28.7M | -$22.3M |
| Cash & equivalents | $144.8M | $40.7M | $43.6M | $43.1M | $53.3M | $41.9M | $16.4M | $17.6M | $10.4M | $8.1M |
| Inventory | $29.7M | $7.6M | $2.1M | — | $3,008 | $143,564 | $338,465 | $428,515 | $594,194 | $166,733 |
| Total assets | $826.1M | $118.8M | $82.1M | $62.0M | $68.9M | $49.3M | $29.5M | $18.8M | $13.5M | $21.9M |
| Total liabilities | $420.8M | $34.2M | $11.9M | $7.0M | $6.1M | $5.1M | $5.8M | $13.9M | $6.3M | $4.1M |
| Shareholders' equity | $405.3M | $84.7M | $70.1M | $55.1M | $62.8M | $44.2M | $23.6M | $4.9M | $7.2M | $17.8M |
Growth · year-over-year · Revenue CAGR 147.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +617.0% | — | — | -65.7% | -20.2% | -15.5% | -34.1% | +30.5% | +47.0% | +6.7% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.